Annual CFO
-$20.41 M
+$568.00 K+2.71%
December 31, 2023
Summary
- As of February 7, 2025, ERNA annual cash flow from operations is -$20.41 million, with the most recent change of +$568.00 thousand (+2.71%) on December 31, 2023.
- During the last 3 years, ERNA annual CFO has fallen by -$12.31 million (-151.92%).
- ERNA annual CFO is now -151.92% below its all-time high of -$8.10 million, reached on December 1, 2020.
Performance
ERNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.29 M
-$4.03 M-178.22%
September 30, 2024
Summary
- As of February 7, 2025, ERNA quarterly cash flow from operations is -$6.29 million, with the most recent change of -$4.03 million (-178.22%) on September 30, 2024.
- Over the past year, ERNA quarterly CFO has dropped by -$1.62 million (-34.84%).
- ERNA quarterly CFO is now -283.77% below its all-time high of -$1.64 million, reached on December 1, 2020.
Performance
ERNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$16.95 M
-$459.00 K-2.78%
September 30, 2024
Summary
- As of February 7, 2025, ERNA TTM cash flow from operations is -$16.95 million, with the most recent change of -$459.00 thousand (-2.78%) on September 30, 2024.
- Over the past year, ERNA TTM CFO has increased by +$3.46 million (+16.93%).
- ERNA TTM CFO is now -805.02% below its all-time high of -$1.87 million, reached on March 1, 2020.
Performance
ERNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ERNA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.7% | -34.8% | +16.9% |
| 3 y3 years | -151.9% | -3.9% | +21.5% |
| 5 y5 years | -151.9% | -3.9% | +21.5% |
ERNA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.1% | -178.2% | +8.0% | -2.8% | +33.5% |
| 5 y | 5-year | -151.9% | +13.1% | -283.8% | +8.0% | -805.0% | +33.5% |
| alltime | all time | -151.9% | +13.1% | -283.8% | +8.0% | -805.0% | +33.5% |
Eterna Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.29 M(+178.2%) | -$16.95 M(+2.8%) |
| Jun 2024 | - | -$2.26 M(-39.7%) | -$16.49 M(-8.9%) |
| Mar 2024 | - | -$3.75 M(-19.6%) | -$18.11 M(-11.3%) |
| Dec 2023 | -$20.41 M(-2.7%) | -$4.66 M(-20.0%) | -$20.41 M(-3.7%) |
| Sep 2023 | - | -$5.83 M(+50.5%) | -$21.18 M(-1.4%) |
| Jun 2023 | - | -$3.87 M(-36.0%) | -$21.47 M(-0.6%) |
| Mar 2023 | - | -$6.05 M(+11.3%) | -$21.59 M(+2.9%) |
| Dec 2022 | -$20.98 M | -$5.43 M(-11.1%) | -$20.98 M(-6.2%) |
| Sep 2022 | - | -$6.12 M(+53.2%) | -$22.37 M(-1.3%) |
| Jun 2022 | - | -$3.99 M(-26.5%) | -$22.68 M(-11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5.43 M(-20.5%) | -$25.49 M(+8.5%) |
| Dec 2021 | -$23.49 M(+189.9%) | - | - |
| Dec 2021 | - | -$6.83 M(+6.4%) | -$23.49 M(+28.4%) |
| Sep 2021 | - | -$6.42 M(-5.6%) | -$18.29 M(+28.1%) |
| Jun 2021 | - | -$6.80 M(+98.4%) | -$14.28 M(+47.8%) |
| Mar 2021 | - | -$3.43 M(+109.4%) | -$9.66 M(+19.2%) |
| Dec 2020 | -$8.10 M | -$1.64 M(-32.0%) | -$8.10 M(+25.3%) |
| Sep 2020 | - | -$2.41 M(+10.2%) | -$6.46 M(+59.3%) |
| Jun 2020 | - | -$2.18 M(+16.6%) | -$4.06 M(+116.6%) |
| Mar 2020 | - | -$1.87 M | -$1.87 M |
FAQ
- What is Eterna Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Eterna Therapeutics?
- What is Eterna Therapeutics annual CFO year-on-year change?
- What is Eterna Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly CFO year-on-year change?
- What is Eterna Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Eterna Therapeutics?
- What is Eterna Therapeutics TTM CFO year-on-year change?
What is Eterna Therapeutics annual cash flow from operations?
The current annual CFO of ERNA is -$20.41 M
What is the all time high annual CFO for Eterna Therapeutics?
Eterna Therapeutics all-time high annual cash flow from operations is -$8.10 M
What is Eterna Therapeutics annual CFO year-on-year change?
Over the past year, ERNA annual cash flow from operations has changed by +$568.00 K (+2.71%)
What is Eterna Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ERNA is -$6.29 M
What is the all time high quarterly CFO for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly cash flow from operations is -$1.64 M
What is Eterna Therapeutics quarterly CFO year-on-year change?
Over the past year, ERNA quarterly cash flow from operations has changed by -$1.62 M (-34.84%)
What is Eterna Therapeutics TTM cash flow from operations?
The current TTM CFO of ERNA is -$16.95 M
What is the all time high TTM CFO for Eterna Therapeutics?
Eterna Therapeutics all-time high TTM cash flow from operations is -$1.87 M
What is Eterna Therapeutics TTM CFO year-on-year change?
Over the past year, ERNA TTM cash flow from operations has changed by +$3.46 M (+16.93%)